| Order from | DifGen Pharmaceuticals |
|---|---|
| Execution period | Initial launches from FY28 |
BSE filing, NSE: APLLTD. Summary written from the filing by ALFA Finder's alert engine.
Alembic Pharmaceuticals Ltd: key numbers
- Share price
- ₹836.20
- Market cap
- ₹16,437 Cr
- Revenue (annual)
- ₹7,345 Cr
- Net profit (annual)
- ₹674.8 Cr
- P/E (TTM)
- 23.7×Sector 41.3×
- Promoter holding
- 69.87%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alembic Pharmaceuticals Ltd
All →Alembic Pharmaceuticals Other Announcement
Alembic Pharmaceuticals Limited has updated its list of Key Managerial Personnel authorised to determine materiality and make stock exchange disclosures. This update follows a board meeting held on November 4, 2026.
Alembic Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹26.03bn (+36% YoY), PAT ₹3.35bn (+81%), EBITDA margin 22% (+520bps). US formulations led growth (+77%).
Alembic Pharmaceuticals Results Update
Alembic Pharmaceuticals reported Q2 FY27 revenue growth of 36% to ₹2,603 Crore. Net profit surged 81% to ₹335 Crore, driven by exceptional US business performance.
- Value
- ₹2,603 Cr
Alembic Pharmaceuticals Q2 FY27 Results: Net Profit ₹335.2 Cr, Up 81.5% YoY
Alembic Pharmaceuticals Ltd reported revenue from operations of ₹2,604 Cr (+36.3% YoY) and net profit of ₹335.2 Cr (+81.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹335.2 Cr · +81.5% YoY
Alembic Pharmaceuticals Board Meeting Date
Alembic Pharmaceuticals scheduled its board meeting for November 4, 2026, to consider unaudited Q1/H1 FY27 results. Trading window re-opens 48 hours post-declaration.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.
Other partnership announcements
All →Grasim Industries Partnership
Grasim Industries, Aditya Birla Renewables, and Suzlon Energy signed a Memorandum of Understanding to develop India's first recyclable wind turbine blades. The partnership utilizes Grasim's Recyclamine technology.
Kothari Industrial Corporation Partnership
Kothari Industrial Corporation signed a five-year MoU with The University of Western Australia. The collaboration spans education, research, mentorships and internships via the UWA Global Engagement Alliance.
- From
- The University of Western Australia (UWA), Australia
- Execution
- five years from the date of the last signature
Rose Merc Partnership
Rose Merc Ltd signed a Lead Marketing, Sales and Project Collaboration Agreement with CATS Eco Systems. No fixed contract value is specified, and no shares are issued.
- Execution
- Five years from November 3, 2026, subject to renewal or earlier termination
Emerald Finance Partnership
Emerald Finance appointed as a Direct Selling Agent by Unity Small Finance Bank to source Gold Loan business Pan India. The filing announces a new business association but states no monetary value.
- From
- Unity Small Finance Bank
Bondada Engineering Partnership
Bondada signed a non-binding MoU with Goa-IPB for proposed ₹3,000 Crore solar and biogas projects in Goa. The deal anticipates 700+ jobs, subject to approvals.
- Value
- ₹3,000 Cr
- From
- Goa Investment Promotion and Facilitation Board (Goa-IPB), Government of Goa
Belrise Industries Partnership
Belrise Industries has signed a licence and technical assistance agreement with Japan's Yamato Co. for filter products. It grants Indian manufacturing rights, with royalty and fees payable.